1. Systemic adverse effects of inhaled corticosteroid therapy: A systemic review and meta-analysis;Lipworth;Arch Intern Med,1999
2. Relationship between systemic corticosteroid exposure and growth velocity: Development and validation of a pharmacokinetic/pharmacodynamic model;Daley-Yates;Clin Ther,2004
3. Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays;Daley-Yates;EurJ Clin Pharmacol,2004
4. Tolerability, safety, pharmacokinetics and bioavailability of the novel intranasal corticosteroid fluticasone furoate in healthy subjects;Allen;Ann Allergy Asthma Immunol.,2007
5. A part-randomised, single dose, open label, 6-way cross-over study to assess the relative systemic pharmacokinetics and absolute bioavailability of 2 and 3 m GW685698X (2000 g), FTIM GW685698X material (2000 g) and FP (1000 g) administered via Diskhaler in healthy male subjects;Upward,2003